Picture of JW (Cayman) Therapeutics Co logo

2126 JW (Cayman) Therapeutics Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Jw (Cayman) Therapeutics Posts IFRS Revenue Rmb145.7 Mln For Year

March 29 (Reuters) - JW (Cayman) Therapeutics Co Ltd
 2126.HK :
    * IFRS REVENUE RMB145.7 MILLION FOR YEAR, INCREASE OF 373.1%
    * LOSS FOR YEAR WAS RMB846.1 MILLION VERSUS LOSS OF RMB702.3
MILLION

Source text for Eikon:  ID:nHKSdvv6d 
Further company coverage:  2126.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on JW (Cayman) Therapeutics Co

See all news